InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by GRASSO MARC, Chief Financial Officer. Director active across 1 companies, notably Kura Oncology, Inc.. Aggregated, 2 disclosures have been published. The latest transaction was disclosed on 26 January 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations2 total
021,900 shares0
Common Stock
SEC:0001209191-22-005391:0·
021,900 shares0
Common Stock
SEC:0001209191-22-005391·
2 of 2 declarations
About GRASSO MARC
Marc Grasso is the Chief Financial Officer and Chief Business Officer at Kura Oncology, Inc. In these roles, he oversees the financial and business management of the company, ensuring compliance and efficiency in operations.
